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As a result of the industrial accident in Bhopal, India (December 1984) in which thousands of people
were exposed to methyl isocyanate (MIC), concern was raised for possible long-term health effects. The
well-recognized immunologic consequences of exposure to other industrial isocyanates prompted inves-
tigation of an antibody response to MIC. Using procedures which had been developed in this laboratory
toevaluate isocyanate immunotoxicity, animal studies wereundertakentodevelopandtestreagentswhich
could be used to detect antibodies to MIC in the exposed population. Guinea pigs were injected with MIC
in its reactive isocyanate form. Three weeks later, blood was drawn and serum evaluated using ELISA.
To detect antibodies, an antigen was prepared by reaction of MIC with guinea pig serum albumin. Anti-
bodies weredetected in each ofthefouranimalsinjectedwithMIC. Titersachievedwere 1:5120to 1:10,240.
Inhibition assays revealed antibody specificity directed toward the MIC hapten. Analogous antigens pre-
pared by reaction ofMIC with human serum albumin were used to evaluate sera from individuals exposed
in Bhopal to MIC. Antibodies were detected in 12 of 144 exposed persons. Antibodies were specific for
MIC, as evidenced by inhibition assays, and belonged to the IgG, IgM and IgE classes. However, titers
were generally low and transient and were found in persons having had the highest MIC exposures. Total
IgE values of sera were not significantly different from those of control sera obtained from Bombay
residents. The results indicate that exposure to methyl isocyanate resulted in production of specific an-
tibodies. However, the low titers observed and the transient nature of the response suggest little health
consequence should result from the antibody response.
Introduction
The accident on the night of December 3, 1984, in
Bhopal, India, resulted in the exposure ofthousands of
residents to methyl isocyanate. At the time, little was
known about either the long- or short-term effects of
exposure to this chemical. However, a considerable
body ofinformation existed regarding the health effects
of other industrial isocyanates, most notably toluene
diisocyanate (TDI), diphenylmethane diisocyanate
(MDI), and hexamethylene diisocyanate (HDI) (1,2).
Isocyanates are recognized as chemicals capable of
causing immunologic sensitization (3). Respiratory hy-
persensitivity, including immediate and delayed onset
pulmonary reactions (4,5), as well as hypersensitivity
pneumonitis (6,7), hasbeennotedinindividualsexposed
to certain isocyanates. Dermal sensitization has been
reported following exposure to other isocyanates, most
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notably to dicyclohexylmethane diisocyanAte (HMDI)
(8,9).
Respiratory sensitivity and dermal sensitization have
beenreproduced inanimalsbytheuse ofinhalation (10-
13)and/ordermal(14)routesofexposure. Theliterature
regardingisocyanatesensitizationhasbeensummarized
and critically evaluated (1-3).
Recent concern has addressed exposure conditions
which would favor sensitization (1,2). Both animal data
(12,15) and human studies (16-18) indicate aconcentra-
tion-dependence of the specific humoral immune re-
sponse to toluene diisocyanate and dose-dependent der-
mal sensitization to TDI, HDI, MDI and HMDI (19).
Due to the causative association ofIgE antibodies with
immediate, and possibly late-onset pulmonary hyper-
sensitivityreactions (20,21), interest has focused on the
detection ofthis class of antibody following accidential
isocyanate exposure (1,17).
The massive MIC exposure in India prompted im-
mediate investigation of the immune response to this
isocyanate. The study reported here identified a hu-
moral immune response to MIC, as tested in an animal
model for isocyanate sensitization. Development and
testing ofappropriate immunologic reagents iti the an-KAROL ET AL.
imal system allowed detection of low levels of MIC an-
tibodies in persons who had received heavy MIC ex-
posure.
Materials and Methods
Animals
Male, English, smooth-haired guinea pigs weighing
approximately 500 g (Hilltop Lab Animals, Inc., Scott-
dale, PA) were used for production of antibodies.
Antigens
Isocyanate conjugate antigens were prepared accord-
ing to a standard procedure (22). Basically, the iso-
cyanate was added dropwise to a stirred solution of
protein dissolved in 0.05 M borate-KCl buffer, pH 9.4,
maintained in an ice bath. A molar ratio of 100:1, iso-
cyanate:protein was typically employed. Reactions
were terminated by addition ofexcess monoethanolam-
ine (Fisher Scientific). Conjugates were purified by is-
oelectric precipitation followed by dissolution in 0.1 M
sodium bicarbonate solution, dialysis, then lyophiliza-
tion. Yield was usually greater than 90%. The reaction
time andtemperature were variedto attain substitution
ofapproximately20to30molehapten/mole protein. The
following antigens were prepared: MIC-guinea pig
serumalbumin (MIC-GSA); MIC-human serumalbumin
(MIC-HSA); MIC-keyhole limpet hemocyanin (MIC-
KLH), TDI-GSA, TDI-HSA, hexamethylene diisocyan-
ate-GSA (HDI-GSA).
Production of Antibody to MIC
Four guinea pigs received intradermal injection with
50 ,uL of 4% MIC (in acetone) into each of two shaved
sites in the shoulder area. Twenty-four days later they
received a second set ofinjections with 2% MIC. Blood
was drawn prior to MIC exposure and again on day 31.
Production of Antibody to MIC-HSA
FouranimalswereinjectedwithMIC-HSAtoprovide
positive control sera to detect human antibodies reac-
tive with MIC. For this purpose, animals were injected
SC with an emulsion containingequal volumes ofa 0.5%
solution MIC-HSA (in saline) and Freund's complete
adjuvant (FCA, Difco, Detroit, MI). Two sites each
received 200 FLL. On days 3 and 21, animals received
booster injections each containing 1.5 mg MIC-HSA in
incomplete Freund's adjuvant. Blood was drawn on day
28.
Antibody Assays
ELISA (Enzyme-Linked Immunosorbent Assay).
ELISA was performed to evaluate both human and an-
imal antisera for the presence of antibodies to methyl
isocyanate. Ninety-six well polystyrene plates were
coated with 100 ,uL antigen (5 ,ug/mL in0.1 M carbonate
buffer, pH 9.6). Antisera were added in 0.1 M phos-
phate-buffered saline, pH 7.4 (PBS), containing 0.5%
Tween 20 (Fisher Scientific Co.) and 0.5% BSA (Sigma
Chemical). The final volume in each well was 100 p,L.
Plates were incubated for 1 hr at 37°C, washed three
times with tween-saline, then reacted with peroxidase-
conjugated anti-guinea pig (or anti-human) reagent
(1:400 dilution). The followingreagents were used: anti-
guinea pig IgG, anti-human IgG, IgM, and IgA (Miles-
Yeda). After incubation at 37°C for 1 hr, plates were
washed, then a solution containing 0.72 mg/mL 5-ami-
nosalicylic acid (Aldrich Chemicals) and 0.006% H202
was added, and incubation continued at37°C for30 min.
Absorbance at 450 nm was measured using a Dynatech
MR 600 Microplate Reader. The titer was defined as
the highest serum dilution givingan absorbance atleast
twice that of control sera, similarly diluted, after sub-
traction of background.
ELISA inhibition assays were performed by incor-
poratingantigenasinhibitorsintothetween-PBSbuffer
immediately prior to dispensing antisera into the wells.
IgE. The total quantity of serum IgE was deter-
mined using a commercial IgE kit (Ventre-Sep, Ven-
trex).
RAST(Radioallergosorbent Test). RAST was per-
formed by coupling MIC-HSA to cyanogen-bromide ac-
tivated paperdiscsusingastandardprocedure (17). The
MIC-HSAantigensusedhadbetween20to40moleMIC
bound per mole protein. For assay, 50 ,uL serum was
incubated with a washed disc at ambient temperature
for 16 hr. After thorough washing of the disc, 125I-la-
beled anti-human IgE (Ventrex Reagent) was added to
detect bound IgE antibody. Titers were expressed as
the percent of added radioactivity which remained
boundtothediscsfollowingthefinalwashingprocedure.
RAST inhibition was performed by reacting 25 ,uL
serum with 25 ,uL inhibitor solution (containing 50 jig
inhibitor) for 2 hr at 37°C prior to addition ofthe MIC-
HSA disc. Thereafter, the RAST procedure was fol-
lowed. Inhibitors included MIC-HSAand HSA. Percent
inhibition was calculated as follows:
(1- _% CPM bound above blank with inhibitorj 100
% CPM bound above blank with buffer /
Statistics
Linear regression analysis was performed using
MINITAB. The two-tailed Student's t-test was used to
compare IgE values in control and exposed cases.
Results
Identification of MIC-Specific Antibodies
in Animals
An animal model was used to determine the ability
of MIC to function as a hapten following in vivo expo-
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sure. Blood was drawn from MIC-exposed animals and
evaluated for specific antibodies using ELISA. Each of
the four guinea pigs injected with MIC produced anti-
bodies. Titers are given in Table 1. The specificity of
these antibodies for MIC was evaluated using ELISA
inhibition assays. Inhibitors tested included various
conjugates containing MIC hapten (MIC-GSA, MIC-
HSA, MIC-KLH) to enable identification of hapten
specificity of antibody, conjugates containing heterolo-
gous isocyanates (HDI, TDI) to indicate possible iso-
cyanate reactivity, protein carriers (GSA, HSA) to in-
dicate protein recognition, and a formaldehyde-GSA
conjugate (23) to provide informationregardingthe fine
specificity ofantibodytoward asmallhapten. Inhibition
assays were performed in triplicate. Results of these
assays using sera from two different animals are shown
in Figures L9 and 1B.
The specificity of antibodies for MIC was apparent.
MIC-GSA, MIC-HSA, and MIC-KLH were effective
inhibitors, whereas the unconjugated proteins, GSA,
HSA, and KLH gave insignificant reaction with anti-
body even at the highest concentration tested (50 jig).
The relative potencies of MIC-conjugates for reaction
with MIC antibody are listed in Table 2; the statistical
parameters ofthe regression lines are listed in Table 3.
With both antisera, MIC-KLH was the most effective
inhibitor, followed by MIC-GSA and MIC-HSA. The
lack of inhibition shown by quantities up to 50 ,ug of
TDI-GSA and HDI-GSA indicates that antibodies were
not directed toward isocyanate groups on the conju-
gates. FailureofHCHO-GSAtoeffectinhibitionfurther
indicated the specificity of antibodies for MIC hapten.
Specificity of Inhibition by MIC-KLH
Severalreasons maybeproposed forthegreaterabil-
ityofMIC-KLH, ascomparedwithMIC-GSAand MIC-
HSA, to inhibit reaction of the animal antisera. The
possibility was explored that inhibition by MIC-KLH
was not specific for MIC determinants, but rather was
due to non-specific interference of MIC-KLH with the
ELISA system. To test this possibility, MIC-KLH was
assayed forinhibitoryactivityinaheterologousantigen-
antibody ELISA system.
An ELISA assay had been developed in this labo-
ratory to detect antibodies to bacterial subtilisin in
guinea pigs exposed to the enzyme via the inhalation
route (Hillebrand et al., personal communication). Us-
ing polyvinyl chloride 96 well microtiter plates (Flow
Laboratories)coatedwith50 ,Lofa50 ,ug/mLsubtilisin
Table 1. Antibody titers to MIC in guinea pigs.a
Animal no. Antibody titer
3060 1:10,240
3061 1:5,120
3062 1:10,240
3063 1:10,240
aAntibody titers were determined by ELISA using peroxidase-
labeled anti-guinea pig IgG (1:400 dilution). Serum from the same
animals taken prior to exposure showed no antibody titer.
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FIGURE 1. Inhibition of ELISA to detect antibodies to MIC in
guinea pigs. Antigens were tested for their ability to react with
anti-MICantibodyandinhibititsbindingtomicrotiterwellscoated
with MIC-GSA. Inhibitors: (A), MIC-KLH; (e), MIC-GSA; (m),
MIC-GSA; (0), GSA; (V), KLH; (0), HSA. Other symbols: no
inhibition was obtained with 50 ,ug or less HDI-GSA or TDI-GSA.
(A) Serum 3060 (1:200 dilution). (B) Serum 3063 (1:400 dilution).
solution, the antiserum titer was 1:20,480. MIC-KLH
in amounts of0.1 and 1.0 j,g was incorporated into the
incubation buffer before addition of antiserum to the
plate; GSA was incorporated into the buffer dispensed
into control wells. Anti-serum to subtilisin was added.
After 2 hr at 37°C, bound antibody was assayed by
addition of alkaline-phosphatase conjugated antiguinea
pig IgG followed by phosphatase substrate. The results
ofthis assay are shown in Table 4. MIC-KLH gave no
inhibition at 0.1 or 1 ,ug. These results indicated that
the inhibition afforded by MIC-KLH in the MIC anti-
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Table 2. ELISA inhibition assays to indicate specificity of MIC
antibodies raised in guinea pigs.
,ug Required for 50%o inhibitiona
Inhibitor Serum #3060 (1:200) Serum #3063 (1:400)
MIC-KLH 0.64 0.27
MIC-GSA 2.90 2.89
MIC-HSA 4.94 5.98
TDI-GSA >50 >50
HDI-GSA >50 >50
HCHO-GSA >50 >50
KLH >50 >50
GSA >50 >50
HSA >50 >50
'Inhibitors were incorporated into the assaybuffer and dispensed
into microtiter wells prior to addition of antibody. The amount re-
quired to effect 50% inhibition of reaction was obtained from linear
regression analysis ofdose-response data shown in Fig. 1.
Table 3. Regression parameters for inhibition regression lines in
Figure l.a
Correlation Log
Inhibitor coefficient slope
Serum #3060 MIC-GSA 0.973 1.54
MIC-HSA 0.998 1.40
MIC-KLH 1.000 1.75
Serum #3063 MIC-GSA 0.986 1.42
MIC-HSA 0.998 1.28
MIC-KLH 0.999 1.12
aLinear least-square regression analysis was performed using
MINITAB.
Table 4. Test for inhibition by MIC-KLH in a heterologous
antigen-antibody (subtilisin) system.a
Antigen Absorbance at 410 nm
None 0.930b
MIC-KLH (0.1 jig) 0.854
MIC-KLH (1.0 ,ug) 0.898
'MIC-KLH was added to microtiter wells that had been coated
withsubtilisin. Antiserum to subtilisin wasadded andbound antibody
detected using phosphatase conjugated-anti-guinea pig IgG.
bEach value represents the mean oftriplicate determinations.
body system was specific and due torecognition ofMIC
antibodies by this antigen.
Evaluation of Sera from Bhopal Patients
Serum was collected from individuals exposed to
methyl isocyanate at various times following the acci-
dent and evaluated for its IgE content (Ventre/Sep,
Ventrex). These values are given in Table 5. In the
exposedpatients, therewas nosignificanttrendinthese
values throughout the year following exposure. Fur-
thermore, incomparingserafromexposed persons with
those from controls, no significant differences were
noted, except in sera drawn in April 1985. However,
no significance is attached to this findingbecause ofthe
single sample constituting the control group.
RAST
RAST was performed to detect the presence ofMIC-
specific IgE antibodies. To determine a positive RAST
titer, cellulose discs were coated with MIC-HSA, and
the assay was performed with sera from control, non-
exposed individuals from India. Values for RAST bind-
ing were regressed against values of total IgE in the
sera. The regression is shown in Figure 2. A strong
correlation existed between these assays; the correla-
tion coefficient for the 41 sera was 0.9223. Using the
95% confidence limits for the line, RAST values above
this limit were considered presumptively positive. Sera
with such values were further evaluated using RAST
inhibition for definitive identification of specific anti-
body. Inhibition of 25% or more by MIC-HSA at 5 jig
was taken as evidence for the presence ofMIC-specific
antibody.
Results of RAST testing are found in Table 6. Five
of the 128 patients tested had antibodies specific for
MIC-HSA, with titers ranging from 6.3 to 11.4% bind-
ing. Inseveralcases, additionalserumsamplescollected
at later time periods were available. Analysis ofthese
samples indicated that the antibody titer typically de-
creased with time from exposure (Table 7).
IgG and IgM Antibodies to MIC
ELISA was used to evaluate sera for the presence of
IgG, IgA, and IgM antibodies to MIC. Controls for
these assays consisted of (a) sera from nonexposed In-
dian donors and (b) sera from guinea pigs which had
been immunized with MIC-HSA (in Freund's adjuvant)
and contained anti-MIC-HSA antibody titers in excess
of1:10,000. Antibodies wereidentified in 10individuals.
AsindicatedinTable6, somepatientsformedantibodies
of more than one class; usually IgG and IgM occurred
together. Titers were uniformly low; a maximum titer
of 1:128 was observed. In some cases, amounts of sera
were insufficient to determine a final titer. However,
in all cases, antibody specificity was confirmed by the
ability of MIC-HSA to inhibit binding.
Relationship Between Exposure
Concentration and Antibody Production
It was ofinterest to determine ifa relationship could
be discerned between the severity ofexposure to MIC
and development ofanti-MIC antibodies. For this pur-
pose, the actual exposure received by individual pa-
tients was estimated from evaluation ofthe symptoms
exhibited atthetimeofexposure. Thesesymptomshave
beendetailed elsewhere(24). Inbrief:exposureseverity
was assessed based upon physical examination, chest
radiograph, spirometry, the patient's need for hospi-
talization, the duration of a serious condition, and oc-
currence of complications.
The development of MIC antibody in patients
groupedaccordingtoexposure severityisgiveninTable
8. It is apparent from this table that IgG and IgM an-
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Table 5. IgE values in serum from individuals exposed to methyl isocyanate.'
Date serum Individuals exposed to MIC Control individuals
collected N IU/mL (SD)b N IU/mL (SD)
December 1984 13 362 (1018) 2 1247 (1923)
January 1985 107 391 (1512) 13 1344 (1937)
February 1985 6 1104 (4755) 6 370 (2068)
March 1985 49 358 (1415) 6 2288 (1998)
April 1985 25 286 (874) 1 4400
May 1985 3 276 (693) c
June 1985 56 682 (2107) 12 424 (1198)
July 1985 10 534 (1334)
December 1985 22 441 (1967) 39 305 (1016)
aNo significant differences were detected between exposed and control values collected during the same month (Student's t-test, two-tailed).
In addition, no trend was detected in values during the year following exposure.
bLogarithmic mean value (SD) expressed in International Units/mL.
'(-), serum not collected.
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FIGURE 2. Total IgE content and MIC-HSA RAST binding of41 sera from control individuals. Data were analyzed using linear least square
regression. 95% confidence limits are indicated. The relationship was highly significant, R = 0.9223.
Table 6. Number of individuals with positive titers of MIC
antibodies.
Antibody class No. positivea/total tested
IgA 0/87
IgE 5/128
IgG 8/118
IgM 7/24
aIgE antibodies were determined by RAST and confirmed by
RAST inhibition as described in the text. IgG, IgM, and IgA anti-
bodies were detectedusing ELISA andconfirnedbyinhibition assay.
tibodies weredetected inthose with severe ormoderate
exposure and in only one individual who had mild ex-
posure. IgE antibody production was associated with
severe exposure as distinguished from those with mod-
erate or mild exposure. A similar finding of IgE anti-
bodyproduction inpatients having acute isocyanate ex-
posure has been reported (17).
Discussion
Industrial experience with isocyanates has indicated
that these chemicals can cause pulmonary hypersensi-
tivityreactions and IgE antibody formation. Moreover,
the antibody response appears to correlate with the
degreeofisocyanate exposure(1,2,5,16-18). Thesefind-
ings were observed in workers accidentally exposed to
isocyanates and were reproduced in animal models of
pulmonary and dermalisocyanate sensitivity (3,10-15).
These results implied that severe exposure to an iso-
cyanate such as MIC would also result in specific anti-
body production and perhaps pulmonary and/or dermal
sensitization.
Animal studies employing MIC were required before
clinical serologic evaluations could be initiated. The an-
imalmodelenableddeterminationofwhetherMICcould
function as a hapten, and whether the antibodies pro-
duced to MIC had haptenic specificity as opposed to
R = 0.9223
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Table 7. Antibody titer to MIC in serum samples collected following exposure.
Date of Total IgE Antibody titer by class
Individual sample (IU/mL) IgMa IgG IgA IgEb (% inhibition)
A 25 Jan 85 308 ND Neg Neg 9.5 (37%)
15 Apr 85 242 ND Neg ND 2.7 (0%)
17 Jun 85 209 ND Neg Neg 3.6 (0%)
B 16Jan 85 880 8 >16 Neg ND
17 Jan 85 803 4 32 ND 6.9 (0%)
5 May 85 880 Neg Neg Neg 4.6 (ND)
aELISA was used to detect IgM, IgG, and IgA antibody. Specificity was confirmed by inhibition assay. Titers are the reciprocal of the
highest serum dilution that gave a positive reading. ND = not determined; Neg = negative.
bRAST was used to detect IgE antibody. Specificity was confirmed by inhibition assay. RAST binding greater than X + 2 SD of control
samples (see Fig. 2), with inhibition greater than 25%, was significant and scored as positive.
Table 8. Immunologic response in individuals with increasing
severity of exposure.
Antibody production
Severity of (no. pos./no. tested)
exposure N IgM IgG IgA IgE
Severe 22 1/7 2/20 0/15 4/22
Moderate 41 4/10 3/39 0/31 1/36
Mild 25 0/3 1/21 0/17 0/18
conjugate reactivity. In addition, by injecting a set of
guineapigswithMIC-HSA, positive serawere obtained
for establishing ELISA assays.
Animals studies demonstrated that MIC was immu-
nogenic in guinea pigs. Inhibition assays indicated that
the antibodies recognized MIC whetherit was bound to
serum albumin or to keyhole limpet hemocyanin. Fur-
thermore, the antibody specificity was not directed ex-
clusively toward the isocyanate (NCO) group, since an-
tibodies gave no reaction with TDI-GSA or HDI-GSA.
Using MIC antigens was found to be effective in de-
tecting guinea pig MIC antibodies; sera from 229 MIC-
exposed individuals were evaluated. Twelveindividuals
demonstrated MIC antibodies. Titers were low and
tended to decline in serum samples taken several
months to ayearfollowingthe exposure. Whether eval-
uation was performed by RAST or ELISA, it was es-
sential to conduct inhibition studies to detect false pos-
itive values caused by either a high amount oftotal IgE
in the serum or other serum factors. Antibodies ofsev-
eral classes were detected; in all cases titers were low.
However, no MIC antibody was detected in any serum
from control, nonexposed individuals from India, al-
though total IgE levels were similar in the exposed and
control samples.
In some cases, inhibition studies of patient sera in-
dicated antibody reactivity with MIC and with human
serum albumin. This finding would imply that in vivo
reaction of MIC with serum albumin had occurred and
had resulted in formation of a complete MIC-HSA an-
tigen. Other evidence suggests that additional proteins
maybe involved in invivo binding ofisocyanates. MIC-
KLH was found to be the most potent inhibitor ofMIC
antibody in guinea pigs. The effectiveness ofthis anti-
gen in reacting with MIC antibodies may have been a
result of high epitope density (molecular weight,
500,000 daltons; 64% ofthe primary amino groups were
reacted with MIC). All binding with this conjugate was
hapten-specific, as there was no binding ofantibody to
KLH. The hapten specificity of antibody implies that
carriers other than serum albumin may have been in-
volved in reaction with MIC.
Recent studies with 14C-TDI offer further indication
of isocyanate binding with proteins other than serum
albumin (25,26). In guinea pigs exposed to TDI by in-
halation, the isocyanate was detected bound to a single
protein of 66 K daltons, which was not serum albumin
(25). Identification ofthisreactantproteinshouldenable
development of even more sensitive assays to detect
isocyanate antibodies. Moreover, in view ofthe depen-
dence ofantibody production onexposure concentration
(12,16-18), recognitionofthisproteinreactantmaypro-
vide an extremely sensitive method for biological mon-
itoringto determine individual exposuretoisocyanates.
The detection of antibody in this study was possible
becauseoftheexquisitesensitivityofRASTandELISA
assays. These tests can detect picogram to nanogram
quantities of antibody. The antibody values reported
here were low and tended to decline with time from
exposure. Forthesereasons, clinicalsignificance ofsuch
titers is doubtful. However, it should be noted that the
detection of antibody with MIC specificity in Bhopal
residents is the only irrefutable evidence that these in-
dividuals were exposed to methyl isocyanate and, con-
sequently, isocyanate toxicity should be given prime
consideration as the causative factor underlying the ob-
served lesions.
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